Kiora Pharmaceuticals (KPRX) Stock Chart & Stock Price History → Are You Positioned For The New Energy Goldrush? (From Wealthpin Pro) (Ad) Free KPRX Stock Alerts $0.49 0.00 (0.00%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Kiora Pharmaceuticals Stock Price Performance5 Day Performance-8.11%1 Month Performance-7.90%3 Month Performance-24.73%6 Month Performance-9.54%Year-To-Date Performance-5.63%1 Year Performance-41.31% Receive KPRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Kiora Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Wealthpin ProAre You Positioned For The New Energy Goldrush?Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it. KPRX Stock Chart for Sunday, June, 2, 2024 KPRX Chart by TradingView Kiora Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$0.50$0.49-0.60%$0.52$0.4841,261 shs$12.95 million05/30/2024$0.53$0.50-6.36%$0.53$0.48111,714 shs$13.03 million05/29/2024$0.54$0.53-1.27%$0.55$0.5092,894 shs$13.91 million05/28/2024$0.55$0.54-1.72%$0.57$0.52123,359 shs$14.09 million05/27/2024$0.55$0.55$0.56$0.5054,600 shs$14.34 million05/24/2024$0.53$0.55+3.04%$0.55$0.5054,647 shs$14.42 million Get the Latest News and Ratings for KPRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kiora Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$0.54$0.53-1.33%$0.55$0.5170,420 shs$13.99 million05/22/2024$0.56$0.54-3.38%$0.56$0.5396,675 shs$14.18 million05/21/2024$0.57$0.56-2.72%$0.58$0.54243,466 shs$14.68 million05/20/2024$0.57$0.57+0.79%$0.58$0.55206,994 shs$15.09 million05/17/2024$0.58$0.57-1.98%$0.60$0.52152,646 shs$14.97 million05/16/2024$0.52$0.58+12.91%$0.59$0.52458,836 shs$15.27 million05/15/2024$0.50$0.52+2.98%$0.52$0.5046,762 shs$13.52 million05/14/2024$0.51$0.50-1.88%$0.51$0.49108,845 shs$13.13 million05/13/2024$0.49$0.51+4.83%$0.52$0.4962,294 shs$13.39 million05/10/2024$0.49$0.49+1.03%$0.52$0.49228,326 shs$12.92 million05/09/2024$0.49$0.49-1.52%$0.50$0.4856,267 shs$12.79 million05/08/2024$0.50$0.49-1.30%$0.52$0.4828,439 shs$12.99 million05/07/2024$0.52$0.50-3.84%$0.52$0.49112,312 shs$13.16 million05/06/2024$0.51$0.52+1.50%$0.54$0.47495,457 shs$13.68 million05/03/2024$0.54$0.51-4.11%$0.56$0.5084,397 shs$13.48 million05/02/2024$0.55$0.54-1.78%$0.56$0.5154,024 shs$14.06 million05/01/2024$0.51$0.55+6.86%$0.56$0.50109,537 shs$14.31 million04/30/2024$0.48$0.51+5.79%$0.51$0.4884,268 shs$13.39 million04/29/2024$0.47$0.48+2.57%$0.50$0.47142,893 shs$12.66 million04/26/2024$0.48$0.47-2.08%$0.50$0.47117,790 shs$12.34 million04/25/2024$0.51$0.48-5.10%$0.49$0.4850,485 shs$12.61 million04/24/2024$0.58$0.51-12.72%$0.52$0.49292,647 shs$13.28 million04/23/2024$0.49$0.58+19.48%$0.64$0.471.23 million shs$15.22 million04/22/2024$0.49$0.49-1.08%$0.49$0.45105,070 shs$12.74 million04/19/2024$0.51$0.49-3.86%$0.53$0.4949,431 shs$12.88 million04/18/2024$0.51$0.51+0.75%$0.52$0.48156,202 shs$13.39 million04/17/2024$0.55$0.51-7.93%$0.56$0.50187,369 shs$13.29 million04/16/2024$0.56$0.55-1.82%$0.58$0.52145,420 shs$14.44 million04/15/2024$0.57$0.56-2.57%$0.58$0.5544,946 shs$14.71 million04/12/2024$0.60$0.57-6.14%$0.62$0.56137,694 shs$14.86 million04/11/2024$0.59$0.60+1.38%$0.62$0.58195,022 shs$15.84 million04/10/2024$0.57$0.59+4.41%$0.60$0.57271,020 shs$15.62 million04/09/2024$0.59$0.57-3.83%$0.61$0.52542,019 shs$14.96 million04/08/2024$0.60$0.59-0.94%$0.62$0.58155,392 shs$15.55 millionThis military-backed stock “owns” AI market (Ad)The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry.04/05/2024$0.58$0.60+2.93%$0.60$0.5789,651 shs$4.60 million04/04/2024$0.59$0.58-1.87%$0.62$0.57172,431 shs$4.47 million04/03/2024$0.59$0.59+0.70%$0.61$0.57444,764 shs$4.55 million04/02/2024$0.60$0.59-2.00%$0.61$0.57254,616 shs$4.52 million04/01/2024$0.71$0.60-15.01%$0.70$0.59544,085 shs$4.61 million03/29/2024$0.71$0.71$0.72$0.60606,030 shs$5.43 million03/28/2024$0.62$0.71+14.41%$0.72$0.60600,819 shs$5.43 million03/27/2024$0.61$0.62+1.16%$0.62$0.6053,894 shs$4.75 million03/26/2024$0.58$0.61+4.97%$0.63$0.55348,308 shs$4.69 million03/25/2024$0.60$0.58-3.15%$0.60$0.56124,632 shs$4.47 million03/22/2024$0.58$0.60+2.86%$0.60$0.5872,247 shs$4.61 million03/21/2024$0.61$0.58-4.83%$0.61$0.5878,144 shs$4.49 million03/20/2024$0.60$0.61+2.84%$0.62$0.5878,202 shs$4.71 million03/19/2024$0.60$0.60-0.67%$0.62$0.53166,937 shs$4.58 million03/18/2024$0.64$0.60-6.12%$0.64$0.60134,271 shs$4.61 million03/15/2024$0.62$0.64+2.42%$0.65$0.6351,499 shs$4.92 million03/14/2024$0.64$0.62-2.82%$0.67$0.6277,253 shs$4.80 million03/13/2024$0.62$0.64+3.23%$0.68$0.62142,551 shs$4.94 million03/12/2024$0.64$0.62-2.96%$0.64$0.62134,502 shs$4.78 million03/11/2024$0.65$0.64-1.91%$0.68$0.62173,460 shs$4.93 million03/08/2024$0.67$0.65-1.88%$0.70$0.65606,732 shs$5.03 million03/07/2024$0.70$0.67-4.84%$0.70$0.6759,050 shs$5.12 million03/06/2024$0.67$0.70+4.62%$0.70$0.65263,056 shs$5.38 million03/05/2024$0.65$0.67+2.91%$0.69$0.64140,877 shs$5.14 million03/04/2024$0.66$0.65-0.75%$0.69$0.64227,949 shs$5.00 million03/01/2024$0.67$0.66-2.38%$0.69$0.63200,660 shs$5.04 million Related Companies: Jaguar Health Stock Chart Carisma Therapeutics Stock Chart Rockwell Medical Stock Chart AEON Biopharma Stock Chart Anebulo Pharmaceuticals Stock Chart Tharimmune Stock Chart Kezar Life Sciences Stock Chart Equillium Stock Chart Eagle Pharmaceuticals Stock Chart CASI Pharmaceuticals Stock Chart Receive KPRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kiora Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KPRX) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kiora Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.